glp 1 helps with inflammation GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Bridging the gap between GLP1-receptor
Description
Editado por: Silvia Pellitero-Rodrguez - University Hospital Germans Trias i Pujol Badalona Federico Vzquez Sanmiguel - University Hospital Germans Trias i Pujol Badalona ltima actualizacin : Octubre 2025 Los frmacos con accin sobre el receptor del pptido similar al glucagn tipo 1 (GLP-1) son efectivos en el tratamiento de enfermedades metablicas asociadas a la obesidad, como la apnea obstructiva del sueo (AOS), la enfermedad heptica metablica (EHMET) y la enfermedad renal crnica (ERC)
With an increasing number of diabetic patients being prescribed these drugs, it is important that eyecare providers understand the implications
Sodium glucose cotransporter-2 inhibition and cardiorenal protection: JACC review topic of the week
Tirzepatide's dual GIP/GLP-1 mechanism produces different side effect profiles than pure GLP-1 agonists
As a result, skin doesnt snap back after volume changes the way it once did and may appear looser or less supported
Be sure to consult with your healthcare provider to tailor your treatment plan to your individual needs
